What is Rapid Novor's aim?
Rapid Novor helps biotech and pharmaceutical companies extract the full potential of antibodies in ways never before possible. They provide services and develop new technology that enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to their Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.
Experts in their field of research
Building upon 20 years of Co-Founder and Chief Scientist Dr. Bin Ma’s scientific research and inventions, Rapid Novor’s team continues to push protein sequencing boundaries. The team behind Rapid Novor comprises world-leading experts in protein chemistry, mass spectrometry and bioinformatics. Their goal is to constantly innovate and create breakthrough technologies to advance life science, which they accomplish continually.